Masashi Ishikawa

发表

Effects of ipragliflozin on the development and progression of kidney disease in patients with type 2 diabetes: An analysis from a multicenter prospective intervention study

Y. Terauchi, M. Miyakawa, Yasushi Tanaka, 2020, Journal of diabetes investigation.

Efficacy and Safety of Adding Sitagliptin in Type 2 Diabetes Patients on Insulin: Age-Stratified Comparison at One Year in the ASSIST-K Study

Y. Terauchi, M. Obana, M. Miyakawa, 2019, Journal of clinical medicine research.

Two-year assessment of the efficacy and safety of sitagliptin in elderly patients with type 2 diabetes: Post hoc analysis of the ASSET-K study

S. Ito, Y. Terauchi, M. Obana, 2015, BMC Endocrine Disorders.

Effectiveness of Ipragliflozin for Reducing Hemoglobin A1c in Patients With a Shorter Type 2 Diabetes Duration: Interim Report of the ASSIGN-K Study

S. Ito, Y. Terauchi, M. Obana, 2017, Journal of clinical medicine research.

Is a Switch From Insulin Therapy to Liraglutide Possible in Japanese Type 2 Diabetes Mellitus Patients?

Y. Terauchi, M. Obana, D. Suzuki, 2014, Journal of clinical medicine research.

Ipragliflozin Improves Glycemic Control and Decreases Body Fat in Patients With Type 2 Diabetes Mellitus

S. Ito, Y. Terauchi, M. Obana, 2017, Journal of clinical medicine research.

Pleiotropic Effects of Sitagliptin in the Treatment of Type 2 Diabetes Mellitus Patients

S. Ito, Y. Terauchi, M. Obana, 2012, Journal of clinical medicine research.

Efficacy and safety of sitagliptin monotherapy and combination therapy in Japanese type 2 diabetes patients

S. Ito, Y. Terauchi, M. Obana, 2012, Journal of diabetes investigation.

Sitagliptin Versus Ipragliflozin for Type 2 Diabetes in Clinical Practice

S. Ito, Y. Terauchi, M. Obana, 2019, Journal of Endocrinology and Metabolism.

Efficacy and Safety of Ipragliflozin in Patients With Type 2 Diabetes: ASSIGN-K Study

S. Ito, Y. Terauchi, M. Obana, 2019 .

Factors Influencing Changes in Hemoglobin A1c and Body Weight During Treatment of Type 2 Diabetes With Ipragliflozin: Interim Analysis of the ASSIGN-K Study

S. Ito, Y. Terauchi, M. Obana, 2016, Journal of clinical medicine research.

Factor Analysis of Changes in Hemoglobin A1c After 12 Months of Sitagliptin Therapy in Patients With Type 2 Diabetes

Y. Terauchi, Kazuyoshi Sato, M. Miyakawa, 2016, Journal of clinical medicine research.

Factors Predicting Therapeutic Efficacy of Combination Treatment With Sitagliptin and Insulin in Type 2 Diabetic Patients: The ASSIST-K Study

Y. Terauchi, M. Obana, M. Miyakawa, 2015, Journal of clinical medicine research.

Safety and efficacy of adding sitagliptin to insulin in patients with type 2 diabetes: the ASSIST-K study.

Y. Terauchi, M. Obana, M. Miyakawa, 2014, Diabetes research and clinical practice.

A Study of Seasonal Variation in the Effect of Add-On Sitagliptin on Blood Glucose Control in Insulin-Treated Patients With Type 2 Diabetes

H. Maeda, A. Mokubo, A. Kubota, 2020, Journal of clinical medicine research.

Classification of 3097 patients from the Japanese melanoma study database using the American joint committee on cancer eighth edition cancer staging system.

Y. Fujisawa, M. Fujimoto, S. Fukushima, 2019, Journal of dermatological science.

Correction: Efficacy and Safety of Ipragliflozin in Japanese Patients With Type 2 Diabetes: Interim Outcome of the ASSIGN-K Study

S. Ito, Y. Terauchi, M. Obana, 2016, Journal of clinical medicine research.

Efficacy and Safety of Ipragliflozin in Japanese Patients With Type 2 Diabetes: Interim Outcome of the ASSIGN-K Study

S. Ito, Y. Terauchi, M. Obana, 2015, Journal of clinical medicine research.

Association of usual sleep quality and glycemic control in type 2 diabetes in Japanese: A cross sectional study. Sleep and Food Registry in Kanagawa (SOREKA)

Y. Terauchi, T. Yamakawa, K. Kadonosono, 2018, PloS one.

Efficacy and Safety of Ipragliflozin in Japanese Patients With Type 2 Diabetes: Interim Outcome of the ASSIGN-K Study

S. Ito, Y. Terauchi, M. Obana, 2015, Journal of clinical medicine research.